Figure 2. GLP-1 infusion significantly increased cardiac muscle MBVand MBF.
Each subject received a systemic infusion of GLP-1 at 1.2 pmol/kg of body mass per min. (A) MBV. (B) MFV. (C) MBF. Results are means±S.E.M. #P < 0.001 and ##P< 0.003 compared with baseline.